Method and composition for treating eating disorders

Method for treating eating disorders in humans and veterinary animals comprising administering to a subject in need thereof a composition comprising (i) an effective amount of mirtazapine, (ii) a cannabis compound selected from the group consisting of CBD and a mixture of CB and up to 50% THC in a dosage amount of mirtazapine to cannabis compound in a ratio of about 1:50 up to about 1:1500;

• (iii) a fat-soluble compound selected from the group consisting of vitamins A, D, E, K and mixtures of the foregoing in an amount effective to inhibit degradation of mirtazapine and cannabis;
• and (iv) a water-soluble vitamin selected from the group consisting of folic acid, folate, vitamin B9 and vitamin B12 and mixtures of the foregoing, thereby increasing the amount of bioavailable mirtazapine and cannabis compound to said subject.

Composition for treating eating disorders in humans and veterinary animals comprising:

• (i) an effective amount of mirtazapine, (ii) a cannabis compound in a dosage amount sufficient to inhibit degradation of mirtazapine;
• and (iii) a fat-soluble vitamin in an amount effective to inhibit degradation of mirtazapine and cannabis compound thereby increasing the amount of bioavailable mirtazapine and cannabis compound to said subject.